The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sun., Sep. 21, 4:08 PM

Slide #14. Opexa Therapeutics, Inc. Secondary Offering

Company: Opexa Therapeutics, Inc. (NASDAQ:OPXA)
Date announced: 9/15/2014
Secondary Offering Details: Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), today announced that it intends to offer shares of its common stock in an underwritten public offering. All of the shares in the offering are to be sold by Opexa. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Opexa Therapeutics is a biopharmaceutical company developing cellular therapies to treat illnesses, including multiple sclerosis (MS). These therapies are based on Co.'s T-cell technology. Co.'s product candidate, Tcelna™, is a T-cell therapeutic vaccine licensed from Baylor College of Medicine. Tcelna™ is a T-cell immunotherapy in clinical development for the treatment of patients with secondary progressive MS. It is also in clinical development for the treatment of patients with relapsing remitting MS. Co. has developed (and, in part, in licensed from the University of Chicago) an adult stem cell technology to produce monocyte-derived stem cells from blood.
Open the OPXA Page at The Online Investor »

Company Name:  Opexa Therapeutics Inc
Website:  www.opexatherapeutics.com
Sector:  Drugs & Pharmaceuticals
 

Open the OPXA Page at The Online Investor (in a new window) »

September 21, 2014    4:08 PM Eastern
Quotes delayed 20 minutes


Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.